Burning Rock Biotech (BNR) Non-Current Assets (2019 - 2026)

Burning Rock Biotech (BNR) has reported Non-Current Assets for 8 consecutive years, with $12.6 million the latest figure, recorded in Q1 2026.

• In Q1 2026, Non-Current Assets fell 2.01% year-over-year to $12.6 million; the TTM figure through Mar 2026 stood at $12.6 million (down 2.01% YoY), while the FY2025 annual figure was $11.7 million, down 21.46% from the prior year.
• Non-Current Assets came in at $12.6 million for Q1 2026 at Burning Rock Biotech, up from $11.5 million in the prior quarter.
• The five-year high for Non-Current Assets was $66.6 million in Q1 2022, with the low at $10.2 million in Q3 2025.
• Average Non-Current Assets over 5 years is $29.4 million, with a median of $27.4 million recorded in 2023.
• Across the five-year window, Non-Current Assets surged 60.36% in 2022 and slumped 64.09% in 2025, its largest moves.
• Year by year, Non-Current Assets stood at $46.2 million in 2022, then tumbled by 53.15% to $21.7 million in 2023, then plunged by 30.12% to $15.1 million in 2024, then slipped by 23.79% to $11.5 million in 2025, then grew by 9.1% to $12.6 million in 2026.
• According to Business Quant data, Non-Current Assets over the past three periods registered $12.6 million, $11.5 million, and $10.2 million for Q1 2026, Q4 2025, and Q3 2025 respectively.